Ditchcarbon
  • Customers
  1. Organizations
  2. Shionogi
Public Profile
Pharmaceutical Preparation Manufacturing
JP
updated 10 days ago

Shionogi

Company website

Shionogi & Co., Ltd., commonly known as Shionogi, is a prominent pharmaceutical company headquartered in Osaka, Japan. Founded in 1878, Shionogi has established itself as a leader in the pharmaceutical industry, focusing on research and development in areas such as infectious diseases, pain management, and central nervous system disorders. With a strong presence in Japan and expanding operations in North America and Europe, Shionogi is renowned for its innovative core products, including antiviral treatments and analgesics. The company’s commitment to advancing healthcare solutions has led to significant milestones, including the development of groundbreaking therapies that address unmet medical needs. Shionogi's dedication to quality and innovation has positioned it as a key player in the global pharmaceutical market, earning recognition for its contributions to public health and patient care.

DitchCarbon Score

How does Shionogi's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

65

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

28

Industry Benchmark

Shionogi's score of 65 is higher than 81% of the industry. This can give you a sense of how well the company is doing compared to its peers.

81%

Let us know if this data was useful to you

Shionogi's reported carbon emissions

In 2023, Shionogi & Co., Ltd. reported total carbon emissions of approximately 214,942,000 kg CO2e globally. This includes 40,373,000 kg CO2e from Scope 1 emissions, 31,650,000 kg CO2e from Scope 2 (market-based), and 142,919,000 kg CO2e from Scope 3 emissions. Notably, the Scope 3 emissions are primarily driven by purchased goods and services, which account for about 81,528,000 kg CO2e. Shionogi has set ambitious climate commitments, aiming to reduce its absolute Scope 1 and 2 greenhouse gas emissions by 46.2% by FY2030/31 from a FY2019/20 baseline. Additionally, the company targets a 20% reduction in Scope 3 emissions from purchased goods and services over the same timeframe. By 2050, Shionogi aims to achieve net-zero emissions across all scopes. In terms of recent performance, Shionogi's Scope 1 emissions in Japan were reported at approximately 40,365,000 kg CO2e for 2023, showing a slight increase from 41,368,000 kg CO2e in 2022. Scope 2 emissions (market-based) also saw a decrease from 34,963,000 kg CO2e in 2022 to 25,759,000 kg CO2e in 2023. The company is on track to meet its near-term targets for Scope 2 emissions, with a goal to reduce these emissions to near zero by 2025. Overall, Shionogi's climate strategy reflects a strong commitment to sustainability and aligns with industry standards for reducing greenhouse gas emissions.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

201820192020202120222023
Scope 1
41,349,000
00,000,000
00,000,000
00,000,000
00,000,000
00,000,000
Scope 2
41,362,000
00,000,000
00,000,000
00,000,000
00,000,000
00,000,000
Scope 3
135,213,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Shionogi's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Shionogi is in JP, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Shionogi is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Janssen

US
•
Pharmaceutical Preparation Manufacturing
Updated 13 days ago

Ironshore Pharmaceuticals Inc.

KY
•
Pharmaceutical Preparation Manufacturing
Updated 13 days ago

Supernus Pharmaceuticals, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 13 days ago

Glaxosmithkline

GB
•
Pharmaceutical Preparation Manufacturing
Updated 4 days ago

DAIICHI SANKYO GROUP

JP
•
Pharmaceutical Preparation Manufacturing
Updated 4 days ago

Genentech

US
•
Pharmaceutical Preparation Manufacturing
Updated 9 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v250807.8
enquiries@ditchcarbon.com+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
Verified byUL Verified
Partnered withCDP
ProductPortalDataDocumentationIntegrationsChangelogPricing
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesMethodologyBlogFAQOrganizationsIndustriesSBTI APITrust Centre
AboutTeamCareersLicense AgreementPrivacy